(Science: chemical) a precursor of noradrenaline that is used in the treatment of parkinsonism. The racaemic form (dl-threo-3,4-dihydroxyphenylserine) has also been used, and has been investigated in the treatment of orthostatic hypotension. There is a deficit of noradrenaline as well as of dopamine in parkinsons disease and it has been proposed that this underlies the sudden transient freezing seen usually in advanced disease. Administration of dl-threo-3,4-dihydroxyphenylserine has been claimed to result in an improvement in this phenomenon but controlled studies have failed to demonstrate improvement. (reynolds jef(ed): martindale: the extra pharmacopoeia (electronic version). Micromedex, inc, englewood, co, 1995)

Pharmacological action: antiparkinson agents.

chemical name: L-Tyrosine, beta,3-dihydroxy-, threo-

Please contribute to this project, if you have more information about this term feel free to edit this page

This page was last modified on 3 October 2005, at 21:16. This page has been accessed 1,387 times. 
What links here | Related changes | Permanent link